Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN56609224
ISRCTN56609224
Completed
Phase 2

Evaluating detection of SARS-CoV-2 antibodies using home test kits (EDSAB-HOME)

Public Health England0 sites4,842 target enrollmentSeptember 21, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Public Health England
Enrollment
4842
Status
Completed
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

2021 Preprint results in https://doi.org/10.1101/2021.01.30.21250777 comparing AbC-19™ Rapid Test, OrientGene COVID IgG/IgM Rapid Test Cassette, SureScreen COVID-19 Rapid Test Cassette, and Biomerica COVID-19 IgG/IgM Rapid Test (added 13/08/2021) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33177070/ AbC-19 Rapid Test (added 13/08/2021) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36135374/ (added 29/09/2022)

Registry
who.int
Start Date
September 21, 2020
End Date
June 1, 2021
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\. Currently working on\-site at their place of work
  • •2\. Aged \=18 years
  • •3\. Able to read English
  • •4\. Has an in\-use personal email address and mobile phone

Exclusion Criteria

  • •1\. Is currently experiencing COVID\-19 compatible symptoms
  • •2\. Has experienced COVID\-19 compatible symptoms in the last seven days
  • •3\. Meets the definition of exceptionally vulnerable” on medical grounds, including immunosuppression, previous oncological treatments – these people should not be at work anyway
  • •4\. Unable to read normal\-sized print with glasses
  • •5\. Taking part in vaccine studies

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Evaluation of assay kit for detecting SARS-CoV-2 infectio
JPRN-UMIN000044225Sekisui Medical Co., Ltd.16
Unknown
Phase 1
Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19)COVID-19
NCT04372004Texas Cardiac Arrhythmia Research Foundation100
Completed
Not Applicable
Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Test Compared to RT-PCR TestCovid19Rapid Antigen TestSARS-CoV-2
NCT04689399Rigshospitalet, Denmark4,697
Unknown
Not Applicable
Evaluation of Rapid Diagnostic Solutions, Serological and Molecular Tests for COVID-19SARS-CoV 2COVID-19
NCT04405492Assistance Publique - Hôpitaux de Paris1,210
Terminated
Not Applicable
Diagnostic Performance of an Antigen Test for SARS-CoV-2 Infection (COVID-19)Covid-19
NCT04610489Carilion Clinic117